{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:30:12Z","timestamp":1786728612435,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Vitamin D (VD) deficiency and insulin resistance (IR) increase the risk of non-alcoholic fatty liver disease (NAFLD), but few studies have explored the potential mechanisms by which IR mediates the association between VD and the pathogenesis of NAFLD at the genetic level using publicly available databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This is a cross-sectional study, and we utilized the National Health and Nutrition Examination Survey (NHANES) dataset, as well as data from GSE200765 obtained from the Gene Expression Omnibus (GEO) website. A total of 723 individuals who had completed liver ultrasound examination and the detection of VD levels were included in the final analysis. A gene expression dataset, GSE200765, was also downloaded from the GEO website, to explore the potential mechanism of VD and NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In the NHANES data, covariates significantly differed in four VD categories, and the controlled attenuation parameter (CAP), vibration-controlled transient elastography-liver stiffness measurement (VCTE-LSM), and IR were reduced with an increase in VD levels. Mediation analysis revealed that IR mediated the association between VD and both CAP and LSM, and the estimated mediation effects were 29.0% and 39.8%, respectively. Bioinformatics analysis showed that seven differentially expressed genes (DEGs) (solute carrier family 2 member 2 [SLC2A2], protein phosphatase 1 regulatory subunit 3E [PPP1R3E], CAMP responsive element binding protein 3-like 3 [CREB3L3], Interleukin-6 [IL-6], peroxisome proliferator-activated receptor gamma coactivator 1-alpha [PPARGC1A], nuclear factor kappa B inhibitor alpha [NFKBIA], and phosphoenolpyruvate carboxykinase 2 [PCK2]) were enriched in the IR pathway in comparison groups (VD group vs. lipid group), suggesting that VD improved NAFLD via changed IR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>VD deficiency and IR were the risk factors for NAFLD, and increased VD levels improved the status of NAFLD. The underlying mechanism may be that elevated VD levels reduced IR, which improved the expression of DEGs involved in the IR pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpvm.ijpvm_221_23","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T13:00:10Z","timestamp":1735563610000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Insulin Resistance Mediates the Association Between Vitamin D and Non-Alcoholic Fatty Liver Disease"],"prefix":"10.4103","volume":"15","author":[{"given":"Caiyan","family":"Zou","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Affiliated Hospital of Southeast University, Xuzhou Clinical School of Nanjing Medical University, Xuzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuekui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Affiliated Hospital of Southeast University, Xuzhou Clinical School of Nanjing Medical University, Xuzhou, Jiangsu, China"},{"name":"Department of Central Laboratory, Xuzhou Central Hospital, Xuzhou Institute of Medical Science, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosheng","family":"He","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Xuzhou Central Hospital, Xuzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Affiliated Hospital of Southeast University, Xuzhou Clinical School of Nanjing Medical University, Xuzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiquan","family":"Sang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Affiliated Hospital of Southeast University, Xuzhou Clinical School of Nanjing Medical University, Xuzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangshan","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Graduate School, Xuzhou Medical University, Xuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Bengbu Medical College, Bengbu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houfa","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Affiliated Hospital of Southeast University, Xuzhou Clinical School of Nanjing Medical University, Xuzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Affiliated Hospital of Southeast University, Xuzhou Clinical School of Nanjing Medical University, Xuzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12]]},"reference":[{"key":"R1-20241230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R2-20241230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ecl.2022.06.007","article-title":"Nonalcoholic fatty liver disease","volume":"52","author":"Isaacs","year":"2023","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R3-20241230","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab"},{"key":"R4-20241230","doi-asserted-by":"crossref","first-page":"101833","DOI":"10.1016\/j.arr.2022.101833","article-title":"Emerging role of aging in the progression of NAFLD to HCC","volume":"84","author":"He","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R5-20241230","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R6-20241230","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.jhepr.2020.100142","article-title":"Cost of non-alcoholic steatohepatitis in Europe and the USA:The GAIN study","volume":"2","author":"O'Hara","year":"2020","journal-title":"JHEP Rep"},{"key":"R7-20241230","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.3390\/nu12113302","article-title":"Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD):An update","volume":"12","author":"Barchetta","year":"2020","journal-title":"Nutrients"},{"key":"R8-20241230","doi-asserted-by":"crossref","first-page":"e1003100","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD):A systematic review and meta-analysis of population-based observational studies","volume":"17","author":"Jarvis","year":"2020","journal-title":"PLoS Med"},{"key":"R9-20241230","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis:A tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"R10-20241230","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"R11-20241230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/iid3.391","article-title":"Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease","volume":"9","author":"Luo","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"R12-20241230","first-page":"Cd005166","article-title":"Drugs improving insulin resistance for non-alcoholic fatty liver disease and\/or non-alcoholic steatohepatitis","author":"Angelico","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-20241230","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.12998\/wjcc.v10.i20.6759","article-title":"Semaglutide might be a key for breaking the vicious cycle of metabolically associated fatty liver disease spectrum?","volume":"10","author":"Cigrovski Berkovic","year":"2022","journal-title":"World J Clin Cases"},{"key":"R14-20241230","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3177\/jnsv.29.271","article-title":"Variation of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 levels in human plasma obtained from 758 Japanese healthy subjects","volume":"29","author":"Kobayashi","year":"1983","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"R15-20241230","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3390\/nu11040794","article-title":"Analysis of association between vitamin D deficiency and insulin resistance","volume":"11","author":"Szymczak-Pajor","year":"2019","journal-title":"Nutrients"},{"key":"R16-20241230","doi-asserted-by":"crossref","first-page":"9016","DOI":"10.3390\/ijms23169016","article-title":"Role of vitamin D in liver disease and complications of advanced chronic liver disease","volume":"23","author":"Ravaioli","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R17-20241230","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.3390\/nu12113302","article-title":"Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD):An update","volume":"12","author":"Barchetta","year":"2020","journal-title":"Nutrients"},{"key":"R18-20241230","doi-asserted-by":"crossref","first-page":"527","DOI":"10.21873\/anticanres.13981","article-title":"Vitamin D in preclinical models of fatty liver disease","volume":"40","author":"Karatayli","year":"2020","journal-title":"Anticancer Res"},{"key":"R19-20241230","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1042\/BCJ20170042","article-title":"Vitamin D deficiency and diabetes","volume":"474","author":"Berridge","year":"2017","journal-title":"Biochem J"},{"key":"R20-20241230","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","article-title":"A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response","volume":"153","author":"Ding","year":"2013","journal-title":"Cell"},{"key":"R21-20241230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12944-017-0477-7","article-title":"VDR Gene variation and insulin resistance related diseases","volume":"16","author":"Han","year":"2017","journal-title":"Lipids Health Dis"},{"key":"R22-20241230","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3390\/nu9080806","article-title":"The association between vitamin D insufficiency and nonalcoholic fatty liver disease:A population-based study","volume":"9","author":"Ha","year":"2017","journal-title":"Nutrients"},{"key":"R23-20241230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ebiom.2017.12.027","article-title":"Vitamin D and nonalcoholic fatty liver disease:Bi-directional mendelian randomization analysis","volume":"28","author":"Wang","year":"2018","journal-title":"EBioMedicine"},{"key":"R24-20241230","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/apt.12377","article-title":"Meta-analysis:Vitamin D and non-alcoholic fatty liver disease","volume":"38","author":"Eliades","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R25-20241230","first-page":"17221","article-title":"Association between vitamin D and non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis:Results from a meta-analysis","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R26-20241230","first-page":"185","article-title":"Vitamin D is associated with severity and mortality of non-alcoholic fatty liver disease:A US population-based study","volume":"5","author":"Kim","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"R27-20241230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5603\/EP.a2023.0002","article-title":"The effect of vitamin D status on non-alcoholic fatty liver disease:A population-based observational study","volume":"74","author":"Dal","year":"2023","journal-title":"Endokrynol Pol"},{"key":"R28-20241230","doi-asserted-by":"crossref","first-page":"1117644","DOI":"10.3389\/fmicb.2023.1117644","article-title":"Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Microbiol"},{"key":"R29-20241230","doi-asserted-by":"crossref","first-page":"7643542","DOI":"10.1155\/2019\/7643542","article-title":"The level of vitamin D in children and adolescents with nonalcoholic fatty liver disease:A meta-analysis","volume":"2019","author":"Zhu","year":"2019","journal-title":"Biomed Res Int"},{"key":"R30-20241230","doi-asserted-by":"crossref","first-page":"e3628","DOI":"10.1002\/dmrr.3628","article-title":"Low 25 (OH) vitamin D levels are associated with increased prevalence of NAFLD and significant liver fibrosis","volume":"93","author":"Ciardullo","year":"2023","journal-title":"Diabetes Metab Res Rev"},{"key":"R31-20241230","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cgh.2022.01.021","article-title":"Inverse association between serum 25-hydroxyvitamin D and nonalcoholic fatty liver disease","volume":"21","author":"Yuan","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R32-20241230","doi-asserted-by":"crossref","first-page":"e3437","DOI":"10.1210\/clinem\/dgac255","article-title":"Resolution of, and risk of incident non-alcoholic fatty liver disease with changes in serum 25-hydroxy vitamin D status","volume":"107","author":"Kim","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-20241230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00125-014-3451-1","article-title":"GLUT2, glucose sensing and glucose homeostasis","volume":"58","author":"Thorens","year":"2015","journal-title":"Diabetologia"},{"key":"R34-20241230","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1742-4658.2005.04585.x","article-title":"A novel glycogen-targeting subunit of protein phosphatase 1 that is regulated by insulin and shows differential tissue distribution in humans and rodents","volume":"272","author":"Munro","year":"2005","journal-title":"FEBS J"},{"key":"R35-20241230","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1210\/en.2014-1113","article-title":"Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes","volume":"155","author":"Nakagawa","year":"2014","journal-title":"Endocrinology"},{"key":"R36-20241230","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.1815150116","article-title":"PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin","volume":"116","author":"Besse-Patin","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"R37-20241230","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/humrep\/der040","article-title":"Nuclear factor-kappa-B-inhibitor alpha (NFKBIA) is a developmental marker of NF-?B\/p65 activation during in vitro oocyte maturation and early embryogenesis","volume":"26","author":"Paciolla","year":"2011","journal-title":"Hum Reprod"},{"key":"R38-20241230","doi-asserted-by":"crossref","first-page":"101257","DOI":"10.1016\/j.molmet.2021.101257","article-title":"Phosphoenolpyruvate carboxykinase in cell metabolism:Roles and mechanisms beyond gluconeogenesis","volume":"53","author":"Yu","year":"2021","journal-title":"Mol Metab"},{"key":"R39-20241230","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2147\/DMSO.S242282","article-title":"Dual SGLT1\/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice","volume":"13","author":"David-Silva","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R40-20241230","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/hep.29751","article-title":"Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride","volume":"67","author":"Stender","year":"2018","journal-title":"Hepatology"},{"key":"R41-20241230","doi-asserted-by":"crossref","first-page":"27857","DOI":"10.1038\/srep27857","article-title":"Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR\/Cas9 system","volume":"6","author":"Nakagawa","year":"2016","journal-title":"Sci Rep"}],"container-title":["International Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.ijpvm_221_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:29:17Z","timestamp":1786724957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.ijpvm_221_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"URL":"https:\/\/doi.org\/10.4103\/ijpvm.ijpvm_221_23","relation":{},"ISSN":["2008-7802","2008-8213"],"issn-type":[{"value":"2008-7802","type":"print"},{"value":"2008-8213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2023-08-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}